BastRCJr, FeeneyM, LazarusH, NadlerLM, ColvinRB, KnappRC. Reactivity of a monoclonal antibody with human ovarian carcinoma.J Clin Invest1981; 68: 1331–7.
2.
OltG, BerchuckA, BastRCJr. The role of tumor markers in gynecologic oncology.Obstet Gynecol Surv1990; 45: 570–7.
3.
O'RiordanDK, DeeryA, DormanA, EpsteinOE. Increased CA 125 in a patient with tuberculous peritonitis: case report and review of published work.Gut1995; 36: 303–5.
4.
BergmannJ-F, BidartJ-M, GeorgeM, BeaugrandM, LevyVG, BohuonC.Elevation of CA 125 in patients with benign and malignant ascites.Cancer1987; 59: 213–17.
5.
MalkasianGD, KnappRC, LavinPT.Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.Am J Obstet Gynecol1988; 159: 341–6.
6.
PennaL, ManyondaI, AmiasA.Intra-abdominal miliary tuberculosis presenting as disseminated ovarian carcinoma with ascites and raised CA 125.Br J Obstet Gynaecol1993; 100: 1051–3.